- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06828185
Essai en simple aveugle randomisé de patient signalé des expériences avec l'épargne fascia oblique externe par rapport à l'orchiectomie inguinale standard (PRESERVE)
The purpose of this study is to evaluate the difference in patient-reported postoperative outcomes between two standard-of-care surgical techniques for radical orchiectomy (inguinal orchiectomy versus external oblique fascia sparing orchiectomy) for treatment of patients with suspected testicular malignancy. The main questions it aims to answer are:
- Does sparing the external oblique fascia during orchiectomy reduce pain after surgery?
- Is there a difference in narcotic consumption after surgery?
- Is there a difference in neuropathic pain after surgery?
- Is there a difference in complications after surgery?
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Radical inguinal orchiectomy is the standard of care surgical approach for removing a testicle when clinically there is concern for testicular cancer. The procedure is generally minor and performed in the outpatient setting. Recent data demonstrates a trend towards high opioid prescription following this procedure in an attempt to minimize postoperative pain, which is associated with persistent new opioid use in the future. Numerous efforts have been put in place to minimize postoperative pain following scrotal procedures, with success noted when opioid sparing pathways have been adopted. However, there has been sparse data on modifications within surgical technique that could improve patient pain following this procedure.
There have been various descriptions of technique to performing a radical orchiectomy which involves removal of the diseased testicle and spermatic cord. Classically, performing a radical inguinal orchiectomy involves incision of the external oblique fascia to expose and ligate the spermatic cord. During this step, the ilioinguinal nerve is exposed and can be injured by either traction injury or inadvertent transection. Modifications to this technique have been described which involve sparing of the external oblique fascia. Both approaches are performed via a similar incision and both the testicle and spermatic cord are removed. In fascia sparing modification, the spermatic cord is controlled, dissected, and subsequently ligated at the level of the superficial inguinal ring without incising the external oblique fascia. Proponents of this approach suggest the potential for less convalescence and faster recovery due to less tissue manipulation and avoidance of disturbances to the ilioinguinal nerve. Despite this potential benefit, there is no evidence to demonstrate superiority of either approach as it relates to patient recovery.
Therefore, we propose a randomized single-blinded clinical trial investigating postoperative pain outcomes of inguinal radical orchiectomy compared to external oblique fascia sparing radical orchiectomy.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Muhannad Alsyouf, MD
- Numéro de téléphone: 44196 9095584000
- E-mail: Malsyouf@llu.edu
Sauvegarde des contacts de l'étude
- Nom: Brian Hu, MD
- Numéro de téléphone: 44196 9095584000
- E-mail: Bhu@llu.edu
Lieux d'étude
-
-
California
-
Loma Linda, California, États-Unis, 92354
- Recrutement
- Loma Linda University
-
Contact:
- Muhannad Alsyouf, MD
- Numéro de téléphone: 44196 9095584000
- E-mail: Malsyouf@llu.edu
-
Chercheur principal:
- Muhannad Alsyouf, MD
-
Los Angeles, California, États-Unis, 90089
- Recrutement
- University of Southern California
-
Chercheur principal:
- Siamak Daneshmand
-
Contact:
- Siamak Daneshmand, MD
- Numéro de téléphone: 3238653589
- E-mail: daneshma@med.usc.edu
-
Sous-enquêteur:
- Hooman Djaladat
-
Sous-enquêteur:
- Anne Schuckman
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Participants undergoing radical orchiectomy for suspected testicular malignancy
- Testicular malignancy can be germ cell tumor or non germ cell tumors, including paratesticular tumors as long as a radical orchiectomy is planned
- Participants over 18 years of age who can provide informed consent
- Participants not currently using opiates for another reason
- Regional and metastatic patients are allowed, as long as participant does not require opiates for pain related to metastatic disease
- No contraindication for participant to receive standardized medication pathway in the peri-operative period.
Exclusion Criteria:
- Clinical T4 disease
- History of illicit substance abuse (including prior opioid abuse) except for marijuana
- Participants who underwent chemotherapy or radiotherapy prior to orchiectomy
- Opioid use within 1 month of study enrollment
- Participants with large testis masses requiring skin incision larger than 8 cm in size.
- Participants with large testis masses requiring orchiectomy through an incision other than the standard transverse inguinal incision (i.e. hockey stick incision, vertical incision)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Orchiectomie inguinale radicale
|
External oblique fascia will be incised during orchiectomy |
|
Comparateur actif: Fascia oblique externe radical
|
External oblique fascia will be spared during orchiectomy |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Postoperative Pain Level
Délai: Change between Postoperative day 0 [the day surgery was completed] through postoperative day 7
|
Post-operative pain levels will be measured by the Short Form Inguinal Pain Score (sf-IPQ) The score range is between 0 and 12, with zero points indicating no pain and 12 points indicating the most intense pain. Scores for subjects undergoing inguinal orchiectomy will be compared to subjects undergoing external oblique fascia sparing radical orchiectomy. |
Change between Postoperative day 0 [the day surgery was completed] through postoperative day 7
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Opioid consumption
Délai: Change between Postoperative day 0 [the day surgery was completed] through postoperative day 7
|
Subjects will self-report the total number of Oxycodone 5 mg tablets consumed for breakthrough pain during the first post-op week. There is no pre-defined range for this self-report but the higher the number of tablets consumed may be an indication of great pain intensity. |
Change between Postoperative day 0 [the day surgery was completed] through postoperative day 7
|
|
Neuropathic Pain Level
Délai: Change between Postoperative day 0 [the day surgery was completed] through postoperative day 7)
|
Post-Operative Neuropathic pain levels will be measured by the modified Barrow Neurological Institute hypesthesia scale. A total score ranging between 1 and 4, with 1 representing minimal neuropathic pain and 4 representing intense neuropathic pain. |
Change between Postoperative day 0 [the day surgery was completed] through postoperative day 7)
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Maladies urogénitales
- Maladies génitales
- La douleur
- Manifestations neurologiques
- Maladies du système endocrinien
- Complications postopératoires
- Processus pathologiques
- Tumeurs génitales, homme
- Tumeurs urogénitales
- Tumeurs par site
- Tumeurs
- Maladies génitales, sexe masculin
- Maladies urogénitales masculines
- Tumeurs par type histologique
- Tumeurs des glandes endocrines
- Troubles gonadiques
- Maladies testiculaires
- Conditions pathologiques, signes et symptômes
- Signes et symptômes
- Douleur, Postopératoire
- Tumeurs, cellules germinales et embryonnaires
- Tumeurs testiculaires
Autres numéros d'identification d'étude
- 5250002
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .